Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Choosing between Sp500 and Total Market funds can shape your retirement. This guide compares performance, diversification, and allocation to help you decide.
28,514 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Private AI secondaries are heating up as Anthropic eyes a potential IPO. Market chatter warns the scene is a pressure...
Blue (OBDC) 2025 earnings could signal how well the firm leverages private credit trends and cost discipline. This gu...
Medicare Part B premiums rose to $202.90 per month in 2026, a 9.7% jump that tightens budgets for retirees. Here’s wh...
Primerica's earnings trajectory hinges on policy sales, investment product performance, and agent distribution. This ...
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
A new set of futures is coming to the CME Group, tying Tesla and SpaceX to a cash-settled futures contract. This arti...
Energy markets swing on geopolitics and supply, but a well-chosen integrated energy stock hold can deliver steady div...
solana price prediction: buying momentum intensifies as on-chain data shows rising accumulation and renewed demand fo...
Chip optimism propelled tech stocks higher as ceasefire reports sparked relief rallies. This guide breaks down what d...
Foreign small-cap value outperformed the S&P 500 by 5.7% in 2026, shaking up the dominance of U.S. stocks and reignit...
New market analysis shows that a $10,000 investment in JPMorgan when Jamie Dimon took over would be worth six figures...